|
|
| SECTION C CHEMISTRY; METALLURGY |
| C 12 | BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING |
| C 12 N | MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material A 01 N 63/00; food compositions A 21, A 23; medicinal preparations A 61 K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A 61 L; fertilisers C 05) |
11/ | 00 | Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof [3] |
11/ | 02 | . | Enzymes or microbial cells being immobilised on or in an organic carrier [3] |
11/ | 04 | . | . | entrapped within the carrier, e.g. gel, hollow fibre [3] |
11/ | 06 | . | . | attached to the carrier via a bridging agent [3] |
11/ | 08 | . | . | the carrier being a synthetic polymer [3] |
11/ | 10 | . | . | the carrier being a carbohydrate [3] |
11/ | 12 | . | . | . | Cellulose or derivatives thereof [3] |
11/ | 14 | . | Enzymes or microbial cells being immobilised on or in an inorganic carrier [3] |
11/ | 16 | . | Enzymes or microbial cells being immobilised on or in a biological cell [3] |
11/ | 18 | . | Multi-enzyme systems [3] |
13/ | 00 | Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves [3] |
15/ | 00 | Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered micro-organisms C 12 N 1/00, C 12 N 5/00, C 12 N 7/00; new plants A 01 H; plant reproduction by tissue culture techniques A 01 H 4/00; new animals A 01 K 67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A 61 K 48/00; peptides in general C 07 K) |
| Note |
| This group covers processes wherein there is a modification of the genetic material which would not normally occur in nature without intervention of man which produce a change in the gene structure which is passed on to succeeding generations. [3] |
15/ | 01 | . | Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor [5] |
15/ | 02 | . | Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion [5] |
15/ | 03 | . | . | Bacteria [5] |
15/ | 04 | . | . | Fungi [5] |
15/ | 05 | . | . | Plant cells [5] |
15/ | 06 | . | . | Animal cells [5] |
15/ | 07 | . | . | Human cells [5] |
15/ | 08 | . | . | Cells resulting from interspecies fusion [5] |
15/ | 09 | . | Recombinant DNA-technology [5] |
15/ | 10 | . | . | Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C 07 H 21/00; preparation of non-structural polynucleotides from micro-organisms or with enzymes C 12 P 19/34) [5] |
15/ | 11 | . | . | DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology C 07 H 21/00) [5] |
15/ | 12 | . | . | . | Genes encoding animal proteins [5] |
15/ | 13 | . | . | . | . | Immunoglobulins [5] |
15/ | 14 | . | . | . | . | Human serum albumins [5] |
15/ | 15 | . | . | . | . | Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin [5] |
15/ | 16 | . | . | . | . | Hormones [5] |
15/ | 17 | . | . | . | . | . | Insulins [5] |
15/ | 18 | . | . | . | . | . | Growth hormones [5] |
15/ | 19 | . | . | . | . | Interferons; Lymphokines; Cytokines [5] |
15/ | 20 | . | . | . | . | . | Interferons [5] |
15/ | 21 | . | . | . | . | . | . | Alpha-interferons [5] |
15/ | 22 | . | . | . | . | . | . | Beta-interferons [5] |
15/ | 23 | . | . | . | . | . | . | Gamma-interferons [5] |
15/ | 24 | . | . | . | . | . | Interleukins [5] |
15/ | 25 | . | . | . | . | . | . | Interleukin-1 [5] |
15/ | 26 | . | . | . | . | . | . | Interleukin-2 [5] |
15/ | 27 | . | . | . | . | . | Colony stimulating factors [5] |
15/ | 28 | . | . | . | . | . | Tumor necrosis factors [5] |
15/ | 29 | . | . | . | Genes encoding plant proteins, e.g. thaumatin [5] |
15/ | 30 | . | . | . | Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria [5] |
15/ | 31 | . | . | . | Genes encoding microbial proteins, e.g. enterotoxins [5] |
15/ | 32 | . | . | . | . | Bacillus crystal proteins [5] |
15/ | 33 | . | . | . | . | Genes encoding viral proteins [5] |
15/ | 34 | . | . | . | . | . | Proteins from DNA viruses [5] |
15/ | 35 | . | . | . | . | . | . | Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [5] |
15/ | 36 | . | . | . | . | . | . | Hepadnaviridae [5] |
15/ | 37 | . | . | . | . | . | . | Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 [5] |
15/ | 38 | . | . | . | . | . | . | Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus [5] |
15/ | 39 | . | . | . | . | . | . | Poxviridae, e.g. vaccinia virus, variola virus [5] |
15/ | 40 | . | . | . | . | . | Proteins from RNA viruses, e.g. flaviviruses [5] |
15/ | 41 | . | . | . | . | . | . | Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses [5] |
15/ | 42 | . | . | . | . | . | . | . | Foot-and-mouth disease virus [5] |
15/ | 43 | . | . | . | . | . | . | . | Poliovirus [5] |
15/ | 44 | . | . | . | . | . | . | Orthomyxoviridae, e.g. influenza virus [5] |
15/ | 45 | . | . | . | . | . | . | Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses [5] |
15/ | 46 | . | . | . | . | . | . | Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [5] |
15/ | 47 | . | . | . | . | . | . | Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus [5] |
15/ | 48 | . | . | . | . | . | . | Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, HIV [5] |
15/ | 49 | . | . | . | . | . | . | . | Lentiviridae, e.g. immunodeficiency viruses, visna-maedi virus, equine infectious anaemia virus [5] |
15/ | 50 | . | . | . | . | . | . | Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus [5] |
15/ | 51 | . | . | . | . | . | Hepatitis viruses [5] |
15/ | 52 | . | . | . | Genes encoding for enzymes or proenzymes [5] |
| Note |
| In this group: |
| | genes encoding for proenzymes are classified with the corresponding genes encoding enzymes; |
| | enzymes are generally categorised according to the "Nomenclature and Classification of Enzymes" of the International Commission on Enzymes. Where appropriate, this designation appears in the groups below in parenthesis. [5] |
15/ | 53 | . | . | . | . | Oxidoreductases (1) [5] |
15/ | 54 | . | . | . | . | Transferases (2) [5] |
15/ | 55 | . | . | . | . | Hydrolases (3) [5] |
15/ | 56 | . | . | . | . | . | acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme [5] |
15/ | 57 | . | . | . | . | . | acting on peptide bonds (3.4) [5] |
15/ | 58 | . | . | . | . | . | . | Plasminogen activators, e.g. urokinase, TPA [5] |
15/ | 59 | . | . | . | . | . | . | Chymosin [5] |
15/ | 60 | . | . | . | . | Lyases (4) [5] |
15/ | 61 | . | . | . | . | Isomerases (5) [5] |
15/ | 62 | . | . | . | DNA sequences coding for fusion proteins [5] |
| Note |
| In this group, the following term is used with the meaning indicated: |
| | "fusion" means the fusion of two different proteins. [5] |
15/ | 63 | . | . | Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression [5] |
15/ | 64 | . | . | . | General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host [5] |
15/ | 65 | . | . | . | using markers (enzymes used as markers C 12 N 15/52) [5] |
15/ | 66 | . | . | . | General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease [5] |
| Note |
| In this group, the following expression is used with the meaning indicated: |
| | "non-functional linkers" means DNA sequences which are used to link DNA sequences and which have no known function of structural gene or regulating function. [5] |
15/ | 67 | . | . | . | General methods for enhancing the expression [5] |
15/ | 68 | . | . | . | . | Stabilisation of the vector [5] |
15/ | 69 | . | . | . | . | Increasing the copy number of the vector [5] |
15/ | 70 | . | . | . | Vectors or expression systems specially adapted for E. coli [5] |
| Notes |
| (1) | This group covers the use of E. coli as host. [5] |
| (2) | Shuttle vectors also replicating in E. coli are classified according to the other host. [5] |
15/ | 71 | . | . | . | . | Expression systems using regulatory sequences derived from the trp-operon [5] |
15/ | 72 | . | . | . | . | Expression systems using regulatory sequences derived from the lac-operon [5] |
15/ | 73 | . | . | . | . | Expression systems using phage lambda regulatory sequences [5] |
15/ | 74 | . | . | . | Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora [5] |
| Note |
| This group covers the use of prokaryotes as hosts. [5] |
15/ | 75 | . | . | . | . | for Bacillus [5] |
15/ | 76 | . | . | . | . | for Actinomyces; for Streptomyces [5] |
15/ | 77 | . | . | . | . | for Corynebacterium; for Brevibacterium [5] |
15/ | 78 | . | . | . | . | for Pseudomonas [5] |
15/ | 79 | . | . | . | Vectors or expression systems specially adapted for eukaryotic hosts; [5] |
| Note |
| This group covers the use of eukaryotes as hosts. [5] |
15/ | 80 | . | . | . | . | for fungi [5] |
15/ | 81 | . | . | . | . | . | for yeasts [5] |
15/ | 82 | . | . | . | . | for plant cells [5] |
15/ | 83 | . | . | . | . | . | Viral vectors, e.g. cauliflower mosaic virus [5] |
15/ | 84 | . | . | . | . | . | Ti-plasmids [5] |
15/ | 85 | . | . | . | . | for animal cells [5] |
15/ | 86 | . | . | . | . | . | Viral vectors, e.g. vaccinia virus [5] |
15/ | 87 | . | . | Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation [5] |
15/ | 88 | . | . | . | using micro-encapsulation, e.g. using liposome vesicle [5] |
15/ | 89 | . | . | . | using micro-injection [5] |
15/ | 90 | . | . | . | Stable introduction of foreign DNA into chromosome [5] |
| |